This article reviews the National Institutes of Health (NIH) classification system for prostatitis and summarizes the baseline analysis of the Chronic Prostatitis Cohort Study, a longitudinal study, which has enrolled 488 patients diagnosed with category III prostatitis. The prevalence of category IIIA in this cohort was 54% to 90%, depending on the cut points used. In all, 8% (37 of 488) had >...

OBJECTIVES Antibiotics are the mainstay for the treatment of men with bacterial prostatitis. Despite numerous treatment strategies involving various types, dosages and duration of antibiotics, no uniform standard has been widely adapted. Moreover, the economic burden of these therapies has been heretofore poorly described. The purpose of this study was to compare the cost effectiveness of vario...

Background. Chronic prostatitis/chronic pelvic pain syndrome remains an urgent urological problem due to unsatisfactory treatment results. Aim. To evaluate the effectiveness of complex therapy chronic prostatitis using special physiotherapeutic methods exposure. Materials and methods. The clinical study involved 49 patients aged 22 47 years with congestive prostatitis. Two groups were made up t...

Chronic prostatitis, which is one of the most common diseases with which the adult male is afflicted [1, 2], covers a wide range of symptoms originating in the prostate. Gartman [3] collected 178 of these symptoms related to the strategic position of the prostate to the urinary, genital and gastro-intestinal tract. A classification based on histological appearance by Swinney [14] divides the cl...

For many patients, the traditional biomedical model that physicians have used to manage chronic prostatitis does not work. This article describes innovative treatment strategies for chronic prostatitis/chronic pelvic pain syndrome, with an emphasis on novel biomedical physical therapy and biopsychosocial approaches to the management of individualized patient symptoms.

Quantitative determinations of U. urealyticum and M. hominis have been performed in 164 men with non-gonococcal urethritis (NGU) and 597 patients with chronic prostatitis. Evidence is provided that U. urealyticum plays an etiologic role in 29.3 percent of patients with non-gonococcal urethritis. Mixed infections of C. trachomatis and U. urealyticum, in high numbers, do occur in 11 percent of NG...